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Purpose: Retinitis pigmentosa includes a group of progressive retinal degenerative
diseases that affect the structure and function of photoreceptors. Secondarily to the loss
of photoreceptors, there is a reduction in retinal vascularization, which seems to influence
the cellular degenerative process. Retinal macroglial cells, astrocytes, and Müller cells
provide support for retinal neurons and are fundamental for maintaining normal retinal
function. The aim of this study was to investigate the evolution of macroglial changes
during retinal degeneration in P23H rats.
Methods: Homozygous P23H line-3 rats aged from P18 to 18 months were used to
study the evolution of the disease, and SD rats were used as controls. Immunolabeling
with antibodies against GFAP, vimentin, and transducin were used to visualize macroglial
cells and cone photoreceptors.
Results: In P23H rats, increased GFAP labeling in Müller cells was observed as an early
indicator of retinal gliosis. At 4 and 12 months of age, the apical processes of Müller cells
in P23H rats clustered in firework-like structures, which were associated with ring-like
shaped areas of cone degeneration in the outer nuclear layer. These structures were
not observed at 16 months of age. The number of astrocytes was higher in P23H rats
than in the SD matched controls at 4 and 12 months of age, supporting the idea of
astrocyte proliferation. As the disease progressed, astrocytes exhibited a deteriorated
morphology and marked hypertrophy. The increase in the complexity of the astrocytic
processes correlated with greater connexin 43 expression and higher density of connexin
43 immunoreactive puncta within the ganglion cell layer (GCL) of P23H vs. SD rat retinas.
Conclusions: In the P23H rat model of retinitis pigmentosa, the loss of photoreceptors
triggers major changes in the number and morphology of glial cells affecting the inner
retina.
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INTRODUCTION
Retinal macroglia, consisting of astrocytes and Müller cells,
play key roles in the homeostasis of retinal neurons, keeping
the retina healthy, and functioning properly. Müller cells, the
largest glial cells in the retina of vertebrates, cover practically
the entire retinal thickness (from the outer to the inner limiting
membrane) and make contact with both neuronal somata and
processes in the entire retina. Müller glial cells are thought to
play an essential role in maintaining the structural integrity of the
retina and to participate in essential processes, such as glucose
metabolism, neurotransmitter uptake, and retinal homeostasis
(Reichenbach and Bringmann, 2013; Chong and Martin, 2015).
Astrocytes, almost entirely restricted to the retinal nerve fiber
layer, have a close relationship with neurons and the major
blood vessels. They are commonly thought to play an important
part in the proper development and functioning of the vascular
system in the retina, including blood flow and the formation
of the blood-retinal barrier (BRB) (Coorey et al., 2012; Kur
et al., 2012; Klaassen et al., 2013). Both astrocytes and Müller
cells are involved in the survival of retinal cells through the
release of neurotrophic factors, providing anti-oxidative support,
clearing neurotransmitters and ions from the extraneural space
and, as in the brain, supporting the formation and removal of
synapses. They are also involved in the activation of microglial
cells and participate in the regulatorymechanisms of vasodilation
and vasoconstriction (Azevedo et al., 2009; Bringmann and
Wiedemann, 2012; Coorey et al., 2012; Bringmann et al., 2013;
Cuenca et al., 2014; Chong and Martin, 2015; Vecino et al.,
2015).
Astrocyte activation and reactive gliosis are common traits
in neurodegenerative processes. A hallmark of gliosis is the
upregulation of intermediate filament proteins in glial cells,
including glial fibrillary acidic protein (GFAP), vimentin, and
nestin (Anderson et al., 2008; Luna et al., 2010). Increasing
evidence points to both the benefits and adverse effects that
reactive gliosis can have on already injured neurons. The
neuroprotective effects of activated glial cells include the
production of neurotrophic factors, growth factors, and cytokines
(Harada et al., 2003; Bringmann et al., 2006), whereas the
dysfunction of glial cells in different pathologies of the retina has
been linked to retinal swelling and BRB breakdown (Shen et al.,
2010; Klaassen et al., 2013). In contrast, chronic gliosis might
accelerate neurodegeneration over the course of a chronic illness,
resulting in both direct and indirect damage to neurons and
the vascular system in the retina. In this context, chronic gliosis
exacerbates the progression of the disease, making vessels more
permeable, and enhancing the infiltration of toxic compounds
(Bringmann et al., 2006; Coorey et al., 2012). Furthermore, in
mature retinas, astrocytes, and Müller cells play a role in the
neovascularization linked to pathological processes, such as age-
related macular degeneration (AMD), diabetic retinopathy (DR),
and retinopathy of prematurity (ROP), as they have been shown
to release angiogenic growth factors in the presence of pathogenic
stimuli (Penn et al., 2008).
Retinitis pigmentosa (RP) is a heterogeneous group of retinal
degenerative disorders with a polymorphic hereditary origin that
cause a progressive loss of retinal function, and it represents a
major cause of blindness. Approximately 20–25% of autosomal
dominant RP patients exhibit a mutation in the rhodopsin gene,
with P23H being one of the most common rhodopsin mutations
(Dryja et al., 1990), accounting for about one-third of such cases
in the USA (Dryja et al., 2000). The P23H mutation is now
known to provoke the retention and misfolding of rhodopsin
in the endoplasmic reticulum (Kaushal and Khorana, 1994).
Some studies have also pointed to a mechanism for RP in
which cellular stress triggers an inflammatory response, which is
followed by retinal remodeling, and the final common pathway
of programmed photoreceptor cell death, i.e., apoptosis (Remé
et al., 1998; Illing et al., 2002; Marc et al., 2003; Jones et al., 2012;
Cuenca et al., 2014). Similar mechanisms have been found in
other forms of retinal degeneration, such as glaucoma, DR, and
AMD (Cuenca et al., 2014).
Transgenic P23H rats have been engineered to mimic human
P23H RP (Dryja et al., 1990, 2000). Although they initially
exhibit normal cone function, these rats develop a progressive
rod dysfunction that is consistent in broad terms with the clinical
findings reported for human patients with P23H RP (Berson
et al., 1991; Machida et al., 2000; Cuenca et al., 2004; Pinilla
et al., 2005). Photoreceptor loss has been observed to accompany
degeneration of the inner retina (Marc et al., 2003; Cuenca et al.,
2004, 2014; Jones and Marc, 2005; Puthussery and Taylor, 2010;
Jones et al., 2012), in addition to considerable degeneration of
retinal ganglion cells (Jones et al., 2003; García-Ayuso et al., 2010;
Kolomiets et al., 2010).
Considering the key role of glial cells in maintaining the
structure, function, and survival of retinal neurons, it is
important to expand our understanding of the cellular changes in
glial cells associated with retinal injuries and neurodegenerative
diseases. The aim of this study was to investigate the evolution
of macroglial changes during retinal degeneration in RP and to
evaluate the role of macroglia in inner retina remodeling after
photoreceptor death. This study uses albino P23H rats at different
ages as animal models of RP.
MATERIALS AND METHODS
Animals
Homozygous albino P23H line three rats (n = 26) obtained from
Dr. M. LaVail (UCSF) were used as a model of RP. Normal SD
rats (n = 26) obtained from Harlan Laboratories (Barcelona,
Spain) were used as wild-type controls. All animals were bred
in a colony at the University of Alicante, Spain, and maintained
under controlled humidity (60%), temperature (23 ± 1◦C) and
photoperiod (LD 12:12) conditions. Light was provided by two
fluorescent lamps, with an intensity of 350–400 lux at cage
level. Dry food and water were made available ad libitum. All
animals were housed, handled and the procedures carried out
according to Project License UA-2013-07-22, approved by the
Ethic Committee for Animal Experiment from the University of
Alicante. All procedures were performed according to current
regulations regarding the use of laboratory animals (NIH, ARVO,
and EuropeanDirective 2010/63/UE), which are intended to limit
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both animal suffering and the number of animals required for
experimentation.
Retinal Histology
Retinal Sections
Animals were sacrificed in the morning, between 10:00 a.m. and
12:00 p.m., by administering a lethal dose of pentobarbital. After
marking the dorsal margin of the limbus with a stitch, the eyes
were enucleated, fixed in 4% (w/v) paraformaldehyde 1 h at room
temperature (RT), washed and then sequentially cryoprotected
in 15, 20, and 30% sucrose. The cornea, lens, and vitreous
body were removed, and the eyecups were processed for vertical
sections or whole mounts. For cryostat sections, eyecups were
frozen in OCT with liquid nitrogen. Fourteen-micrometer-thick
sections were then obtained using a Leica CM 1900 cryostat
(Leica Microsystems, Wetzlar, Germany) mounted on Superfrost
Plus slides (Menzel GmbH & Co KG, Braunschweig, Germany)
and air-dried. Before further processing, the slides were washed
three times in phosphate buffer (PB), and then treated with
blocking solution (10% normal donkey serum in PB plus 0.5%
TritonX-100) for 1 h.
Retinal Immunofluorescence
In order to objectively compare them, retinas from P23H and
SD rats were fully processed in parallel. All primary antibodies
and lectins used in this work (summarized in Table 1) have been
previously used in other studies and have been well characterized
by us and other authors with regard to the specific cell type
molecular markers. Sections and whole mount retinas were
either single- or double-immunostained at room temperature
overnight or for 3 days, respectively, using combinations of
antibodies targeting distinct molecular markers. The dilutions
in PB with 0.5% Triton X-100 are indicated in Table 1.
Afterwards, Alexa Fluor 488 (green)-conjugated anti-rabbit IgG
and/or Alexa Fluor 555 (red)-conjugated anti-mouse IgG donkey
secondary antibodies from Molecular Probes (Eugene, OR) were
added at a dilution rate of 1:100 for 1 h for sections and
overnight for whole mount retinas. TO-PRO-3 iodide (Molecular
Probes) was used as a nuclear marker. Finally, the retinas were
washed in PB, mounted in Citifluor (Citifluor Ltd, London,
UK) and coverslipped for viewing with laser-scanning confocal
microscopy on a Leica TCS SP2 system (Leica Microsystems).
Immunohistochemical controls were carried out by omitting
either the primary or secondary antibodies. The resulting images
from the control and experimental subjects were processed in
parallel with Adobe Photoshop 10.0 software (Adobe Systems
Inc, San José, CA, USA).
Astrocyte Quantification
Astrocytes were quantified on whole-mount retinas at different
ages. Immunolabeling against GFAP and the nuclear marker
TO-PRO-3 were used to identify astrocytes. Lectin was used
to visualize blood vessels. Twelve representative regions, each
measuring 0.227mm2, were analyzed from each retina: six
equidistant regions on the superior-inferior axis and six fields
on the temporal-nasal axis. This ensured representative sampling
of the peripheral, medial and central zones of the upper, lower,
temporal, and nasal quadrants of each retina. In all 12 regions,
each astrocyte cell body was manually counted in two adjacent
confocal images and the cell density values were averaged. To
avoid overestimation of astrocyte density, only GFAP-positive
cells with a well-defined nucleus were included in the count. At
least three rats were used for each experimental group.
Immunoblotting
GFAP and connexin 43 protein expression was assessed using
Western blotting on P23H and SD rat retinas at 4 and 12 months
of age (four rats per experimental group). Briefly, proteins were
extracted and subjected to immunoblotting analysis. Proteins
(30µg/lane) were resolved by SDS-PAGE on 12% polyacrylamide
gels and electrotransferred to nitrocellulose membranes (GE
Healthcare, Buckinghamshire, UK). Membranes were blocked in
5% bovine serum albumin (BSA) diluted in 25mM Tris (pH 8.0),
150mM NaCl, 2.7mM KCl (TBS) with 0.1% v/v Tween 20 for
2 h. Afterwards, membranes were probed at 4◦C overnight with
rabbit polyclonal GFAP or connexin 43 antibodies diluted in TBS,
and with mouse monoclonal GAPDH antibodies (see working
dilutions on Table 1). After incubation with primary antibodies,
TABLE 1 | Primary antibodies and lectins used in this work.
Molecular marker (initials) Antibody/lectin Company Catalog ref. Working dilution
IHC WB
Glial fibrillary acidic protein (GFAP) Mouse, G-A-5 Sigma G 3893 1:500 –
Glial fibrillary acidic protein (GFAP) Rabbit, polyclonal Dako N1506 1:50 1:1000
Transducin, Gαc subunit (Gt) Rabbit, polyclonal Cytosignal PAB-00801-G 1:200 –
Vimentin Mouse, V9 DAKOCytomation M0725 1:100 –
Connexin 43 (Cx43) Rabbit, polyclonal Sigma C 6219 1:1000 1:10000
Griffonia simplicifolia IB4 (GS-IB4) Isolectin IB4 Invitrogen I21411 1:100 –
Collagen type IV Goat, polyclonal Millipore AB769 1:100 –
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) Mouse, 6C5 Millipore MAB374 – 1:10000
Primary antibodies and lectins used in this work. The two first columns list the antigen and the animal origin of the antibody. The clone code is specified for monoclonal antibodies. The two
central columns provide the commercial company and antibody catalog reference. The two last columns specify the dilution at which each antibody was used for immunohistochemistry
(IHC) or immunoblotting (WB).
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the membranes were incubated at room temperature for 1 h with
horseradish peroxidase-conjugated goat anti-rabbit or goat anti-
mouse (Pierce, Rockford, IL, USA) IgG at a 1:10,000 dilution.
Detection was performed by enhanced chemiluminescence using
the SuperSignal West Dura system (Pierce).
Western blot films were digitized using a scanner in
transparency mode at 300 dpi and 16 bits gray scale.
Densitometric quantitation of protein bands was accomplished
using the Quantity One software from BioRad (Hercules, CA,
USA), and the values obtained for each protein were normalized
to GAPDH levels. For each quantified protein, we analyzed the
results of at least two independent experiments.
Statistical Analysis
A Two-way ANOVA was used to evaluate the effects of genotype
(SD vs. P23H) and age (P18 to 16 months), alone and in
combination. When the level of significance was 0.05 or less,
post-hoc pairwise comparisons using Bonferroni’s test were
performed. Normal distribution and homogeneity of variance
were determined for the categories of the previously defined
variables. Data are reported as mean ± SEM. Values of P <
0.05 were considered to be statistically significant. All statistical
analyses were performed using SPSS 15.0 software (Statistical
Package for Social Sciences, Chicago, IL, USA). All counts were
made by two trained observers, using a blind methodology.
RESULTS
Astrocyte Morphology and Distribution in
Normal and Degenerating Rat Retinas
P23H rat retinas undergo neurodegenerative changes associated
with the progression of the disease. To assess the evolution
of astrocyte changes during retinal degeneration, the cell
density and morphology of retinal astrocytes were studied at
different ages in normal and diseased retinas through the
immunocytochemical localization of GFAP. Figure 1 illustrates
the distribution and cell density of astrocytes in whole-mounted
retinas from SD (Figures 1A,B) and P23H (Figures 1C–F) rats.
In normal and diseased retinas, astrocytes were distributed in
a plexus located on the ganglion cell layer (GCL). In P23H rat
retinas, GFAP-positive Müller cell end-feet were observed at the
GCL from P120 to P480 (Figures 1D–F, arrowheads).
Astrocyte quantification showed that astrocyte density
gradually increased from the periphery toward the central
area of the retina in both SD and P23H rats at all ages
analyzed (Figures 2B,D,F,H). In addition, the astrocyte density
was higher in the temporal and superior areas of the retina
(Figures 2A,C,E,G). In both SD and P23H rats, astrocyte density
was significantly lower in adults as compared to P18 aged rats
(ANOVA, Bonferroni’s test, P < 0.001; Figure 2I), and the mean
density of astrocytes increased slightly from P120 to P480 in both
SD and P23H rats, with significant differences between P120
and P480 SD rats (ANOVA, Bonferroni’s test, P < 0.01). On the
other hand, a significant increase in astrocyte cell numbers was
found in P120 and P360 P23H rat retinas, as compared to control
SD rats (ANOVA, Bonferroni’s test, P < 0.05; Figure 2I), with
significant differences in all retinal regions analyzed (ANOVA,
Bonferroni’s test, P < 0.05; Figures 2C–F).
In both normal and diseased retinas, astrocytes showed
the characteristic morphology, with flattened cell body and
a series of fibrous radiating processes. As illustrated in
Figure 3, astrocyte processes, and even occasionally, astrocyte
cell bodies were intimately associated with the blood vessels of
the superficial retinal vascular plexus, with astrocyte end-feet
encircling endothelial cells (Figures 3A–C, arrowheads). In P23H
rats, astrocytic hyperplasia was associated to astrocyte process
hypertrophy accompanied by increased GFAP immunoreactivity.
Interactions between astrocyte cell bodies and blood vessels were
less evident (Figure 3D) inmore advanced stages of degeneration
(P480).
In 12- and 18-month-old SD rat retinas, astrocytes with
normal morphology and distribution were closely associated
with typical retinal blood vessels (Figures 4A,C). However,
at these ages, P23H rats showed a progressive disruption
of the superficial vascular plexus, exhibiting tortuous vessels
(Figures 4B,D). Blood vessels were significantly regressed, and
loops largely degenerated.Moreover, P23H rat retinas showed the
formation of blood vessel tangles at 12 (Figure 4E, arrows) and
18 (Figure 4F, arrows) months of age. Figures 4B,D show that
superficial vascular plexus degeneration was associated with the
loss of normal morphology in astrocyte cells.
Increase of Connexin 43
Immunofluorescence in P23H Rat Retinas
Connexin 43 (Cx43) is the most abundant gap junction protein
in the central nervous system (CNS) including retina, and
is expressed mainly on astrocyte processes surrounding blood
vessels (Nagy and Rash, 2000; Zahs et al., 2003; Kerr et al.,
2010). To determine the relationship between the expression of
Cx43 and astrocytic hyperplasia and hypertrophy in the P23H
rat retina, whole-mounted retinas from P120 SD and P23H rats
were double-labeled with antibodies against Cx43 and GFAP.
In both SD and P23H rats, Cx43-immunoreactive (IR) puncta
were located along GFAP-IR astrocyte processes in the GCL
(Figure 5). However, the density of Cx43-IR puncta within the
GCL was greater in P23H (Figures 5C,D) vs. SD rat retinas
(Figures 5A,B).
To quantify the differential expression of Cx43 gap junction
proteins in normal and diseased retinas, we performed
immunoblotting in 4- and 12-month-old rat retinas from SD and
P23H rats (Figures 5E,F). A 43-kDa band corresponding to Cx43
protein was observed, which wasmore intense in P23H rat retinas
than in SD controls (Figure 5E). Antibodies against GAPDH
(36 kDa) were used as loading controls for Western blotting
experiments. The amount of Cx43 protein present in each band
was densitometrically measured and the value obtained for
each sample was normalized to GAPDH levels. The normalized
expression levels were significantly upregulated in the diseased
rat retinas as compared to controls. Expression fold changes were
calculated as the ratio between the P23H and control normalized
values. In particular, Cx43 levels were found to be increased
2.25- and 1.81-fold in the 4- and 12-month-old P23H rat retinas,
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FIGURE 1 | Distribution and density of astrocytes in SD and P23H rat retinas. (A–F) Whole-mounted retinas from SD (A,B) and P23H rats (C–F) at P18 (A,C),
P120 (D), P360 (E), and P480 (B,F) showing retinal astrocytes (red) at the nerve fiber layer and blood vessels (green). Nuclei were stained with the nuclear marker
TO-PRO 3 (blue). Astrocytes have been labeled with antibodies against GFAP. Blood vessels have been labeled with Griffonia simplicifolia isolectin B4. All images were
collected from the medial area of the retina. Note the presence of GFAP positive Müller cell end-feet in P23H rats at P120 (D, arrowheads), P360 (E, arrowheads), and
P480 (F, arrowheads). Scale bar: 40µm.
respectively, as compared to controls (ANOVA, Bonferroni’s test,
P < 0.001 in both cases).
Increased Müller Cell Expression of
Vimentin and GFAP in P23H Rat Retinas
GFAP expression in Müller cells is an indicator of tissue stress,
and it has been associated with retinal degeneration, whereas the
intermediate filament protein vimentin is ubiquitously expressed
in the Müller cells of many mammalian species. Figure 6 shows
the immunohistochemical localization of GFAP and vimentin
in vertical retinal sections from SD (Figures 6A–C) and P23H
(Figures 6D–L) rats. In Müller cells from normal retinas,
vimentin immunostaining was distributed throughout the entire
processes, from their end-feet up to the outer retina (Figure 6A),
while GFAP immunoreactivity was virtually limited to the inner
margin of the retina, colocalizing with astrocytes (Figure 6B). In
fact, the colocalization of vimentin and GFAP was negligible in
SD rats (Figure 6C).
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FIGURE 2 | Astrocyte density in SD and P23H rat retinas. Quantification of the cell density of astrocytes in whole-mounted retinas from SD (green) and P23H rats
(red). Astrocytes were quantified on representative sampling of the peripheral, medial, and central zones of the upper, lower, temporal, and nasal quadrants of each
retina at P18 (A,B), P120 (C,D), P360 (E,F), and P480 (G,H). Mean density values for all representative samplings are represented in (I). Data are reported as mean ±
SEM. *P < 0.05; **P < 0.01.
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FIGURE 3 | Morphological and structural features of astrocytes in SD and P23H rat retinas. Whole-mounted retinas from a P120 SD rat (A) and P23H rats at
P120 (B), P360 (C), and P480 (D), showing retinal astrocytes (red) at the nerve fiber layer and blood vessels (green). Nuclei were stained with the nuclear marker
TO-PRO 3 (blue). Astrocytes have been labeled with antibodies against GFAP. Blood vessels have been labeled with G. simplicifolia isolectin B4. All images were
collected from the medial area of the retina. Note the presence of GFAP positive Müller cell end-feet in P23H rats at P480 (arrows). Scale bar: 20µm.
In P23H rats, vimentin immunoreactivity within Müller
cells was similar to that observed in age-matched control rats
(Figures 6A,D,G,J). However, diseased retinas showed intense
GFAP immunoreactivity in Müller cells, which exhibited a
marked labeling throughout the entire cell (Figures 6E,H,K).
Thus, double staining for vimentin and GFAP revealed
extensive colocalization of both intermediate filament proteins
in these rats (Figures 6F,I,L). Vimentin/GFAP-positive Müller
cell apical processes extended into the subretinal space. These
glial components expanded, filling areas previously occupied
by degenerated photoreceptors (Figures 6D–F, arrows). In
agreement with previous reports (Cuenca et al., 2004, 2014), 4-
month-old P23H rats showed around two rows of photoreceptor
cell bodies in the central area of the retina, whereas 4-month-
old SD rats showed around 12 photoreceptor rows in the same
area. At 18 months of age and thereafter, photoreceptor cells
were virtually absent from P23H rat retinas (data not shown).
At 12 and 18 months of age, Müller cells have lost their parallel
arrangement at IPL level, and their lateral branches had become
enlarged and chaotically entangled (Figures 6G–L, arrows).
GFAP protein expression was assessed by Western blotting
on P23H and SD rat retinas at 4 and 12 months of age
(Figures 7A,B). A prominent GFAP bandwith an estimated SDS-
PAGE molecular weight of ∼55 kDa was observed in P23H rat
retinas compared to SD controls (Figure 7A). Antibodies against
GAPDH (36 kDa) were used as loading controls for Western
blotting experiments. Thereafter, the amount of GFAP protein
present in each band was densitometrically measured and the
value obtained for each sample was normalized to GAPDH levels.
The normalized expression levels obtained revealed a marked
difference of expression between diseased rat retinas and controls
(Figure 7B). Expression fold changes were calculated as the ratio
between the P23H and control normalized values. Specifically,
we observed a 7.8- and 5.3-fold increase in GFAP expression in
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FIGURE 4 | Superficial vascular plexus in SD and P23H rat retinas.
Whole-mounted retinas from SD rats (A,C) and P23H rats (B,D–F) at P360
(A,B,E), and P540 (C,D,F), stained for collagen IV (green) and GFAP (red) in
order to show the relationship between blood vessels and astrocytes,
respectively, during retinal degeneration. During aging, blood vessels in P23H
rat retinas (B,D) suffered alterations related to astrocyte changes that were
unobserved in SD rats (A,C). Note the formation of blood vessel tangles at
P360 (E, arrows) and P540 (F, arrows). Scale bar: 100µm (A,D), 40µm (E,F).
the retina of P23H rats, as compared to the control animals at
the ages of 4 and 12 months, respectively (ANOVA, Bonferroni’s
test, P < 0.001 in both cases). Protein expression analysis also
showed significantly greater GFAP levels in P360 vs. P120 P23H
rat retinas (ANOVA, Bonferroni’s test, P < 0.01), indicating
that GFAP expression increased in P23H rats during retinal
degeneration. This age-related GFAP overexpression in P23H
rats was in parallel with the higher GFAP immunoreactivity
observed in both astrocytes and Müller cells (Figures 3, 6).
Expanded Müller Cell Processes in P23H
Rat Retinas
Müller cells span across the entire thickness of the neural retina
and are essential in maintaining the neuroretinal architecture.
In order to assess glial remodeling in degenerative P23H rat
retinas, GFAP immunoreactivity was analyzed in the ONL of
whole-mounted retinas from SD and P23H rats (Figure 8).
In normal retinas, specific GFAP staining was absent in the
ONL throughout the retina. However, in diseased retinas,
the considerable loss of photoreceptors within the ONL was
linked to the appearance of hypertrophied side branches of
Müller cells into the outermost photoreceptor layer. At 4 and
12 months of age, apical GFAP-positive Müller cell processes
were arranged in clusters, forming characteristic firework-like
structures (Figures 8A–C). This peculiar distribution of Müller
cell processes in the ONL was not present at 16 months of age
(Figure 8D).
At 12 months of age in P23H rats, whole-mount retinas
showed that most of the cones exhibited a short morphology,
indicating a degenerated state (Figures 9A,B, arrowheads). The
loss of rod photoreceptors altered the cone mosaic in the ONL.
The regular distribution and orientation of cones was disrupted
by the appearance of ring-like shaped areas of cone degeneration
(Figures 9C,D). A double staining with GFAP and γ-transducin
for simultaneous labeling of reactive Müller and cone cells
showed a spatial correlation between ring-like shaped areas
of cone cells and firework-like structures of Müller cell apical
processes in P360 P23H rats (Figures 9B,C). It is interesting to
note that some of the cones arranged in parallel on the Müller
cell processes showed a normal morphology, with long axons
and well-defined outer segments (Figures 9E,F, arrowheads).
The morphology of normal and degenerating cones in vertical
retinal sections from a SD and P23H rat retinas is shown in
Supplementary Figure 1.
DISCUSSION
The response of the retina to injury results in a set of cell signals
that lead to morphological and functional changes, including
controlled cell death, and retinal remodeling (Marc et al., 2003;
Jones and Marc, 2005; Cuenca et al., 2014). In this context,
glial cells play a critical role, and the inflammatory response
to injury can be decisive for maintaining the health of the
retina or its degeneration (Bringmann et al., 2006; Bringmann
and Wiedemann, 2012; Noailles et al., 2014; Hippert et al.,
2015). Nevertheless, only a handful of longitudinal studies have
considered gliosis in the retina. The current study provides
evidence of the common and distinctive features of macroglial
changes during retinal degeneration in the P23H rat model of RP.
In P23H rats, retinal astrocytes were activated, proliferated,
exhibited enlarged soma and thickened processes, and increased
GFAP immunoreactivity. In many mammalian retinas, the
density and morphology of astrocytes are strongly influenced
by the nearby axons from ganglion cells, and a loss of retinal
ganglion cell axons has been linked to a reduced density of
astrocytes (Karschin et al., 1986; Gargini et al., 1998). In normal,
healthy retinas, astrocytes are densely packed around blood
vessels, with larger cells around the veins and smaller ones
surrounding the arteries (Jammalamadaka et al., 2015). Here, we
showed that retinal astrocyte density in both SD and P23H rats
gradually increased from the periphery toward the center of the
retina, likely following the center to periphery decrease in retinal
neuronal and blood vessel density.
Previous studies have reported that the number of astrocytes
in the Wistar rat retina increases between 3 and 9 months and
decreases between 9 and 12 months (Mansour et al., 2008). A
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FIGURE 5 | Connexin 43 expression in SD and P23H rat retinas. Whole-mounted retinas from a SD rat (A,B) and a P23H rat (C,D) at P120. Connexin 43 (Cx43,
green) and GFAP immunolabeling (red) show the relationship between retinal astrocytes and Cx43-immunoreactive (Cx43-IR) puncta. Note that Cx43-IR puncta are
located along GFAP-IR astrocyte processes (B,D) and are more numerous in P23H rat retinas (C,D), as compared to the control SD rat retinas (A,B). Scale bar:
20µm. (E) Detection of Cx43 (43 kDa) in P23H rat retinas and SD controls by Western blotting at P120 and P360. GAPDH (36 kDa) levels are shown as loading
controls. (F) The amount of Cx43 protein present in each band was densitometrically measured and the value obtained for each sample was normalized to GAPDH
levels. Bars represent the average ± SEM (n = 4). **P < 0.01; ***P < 0.001.
similar age-related decrease in the number of astrocytes has been
observed in the human retina (Ramírez et al., 2001). Our results
revealed a slight, progressive increase in astrocyte density in
rats at 4, 12, or 16months of age. On the other hand, in both
SD and P23H rats, astrocyte density was significantly lower in
adult rats as compared to that observed at P18. This can be
attributed, at least partially, to the increase in the relative size
of the retina during the postnatal development. The decline in
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FIGURE 6 | Immunofluorescence of vimentin and GFAP in SD and P23H rat retinas. Vertical retinal sections from P120 SD rats (A–C) and P23H rats at P120
(A–F), P360 (G–I), and P540 (J–L). Nuclei were stained with the nuclear marker TO-PRO 3 (blue). Immunostaining with GFAP (green) and vimentin (red) shows
reactive changes in Müller cells associated with retinal degeneration in P23H rats. All images were collected from the medial area of the retina. ONL, outer nuclear
layer; OPL, outer plexiform layer; INL, inner nuclear layer; IPL, inner plexiform layer; GCL, ganglion cell layer. Scale bar: 20µm.
FIGURE 7 | GFAP expression in SD and P23H rat retinas. (A)Detection of GFAP (apparent molecular weight of 55 kDa) in P23H rat retinas and SD controls by
Western blotting at P120 and P360. GAPDH (36 kDa) levels are shown as loading controls. (B) The amount of GFAP protein present in each band was
densitometrically measured and the value obtained for each sample was normalized to GAPDH levels. Bars represent the average ± SEM (n = 4). **P < 0.01;
***P < 0.001.
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FIGURE 8 | GFAP-positive Müller cell apical processes in P23H rat retinas. Whole-mounted retinas from P23H rats at P120 (A), P360 (B,C), and P480 (D),
showing GFAP-positive Müller cell processes distributed in the ONL. The retinas were flat-mounted with the photoreceptor layer facing up. Note the characteristic
firework-like structures generated by Müller cells. Scale bar: 1mm (A,B), 40µm (C), 100µm (D).
the number of astrocytes from early postnatal age may also be
associated with a reduction in the number of retinal ganglion
cells during the postnatal development. Previous studies have
reported a significant decrease in ganglion cell numbers in the
retina of newborn rats during the early weeks of the postnatal
period (Perry et al., 1983).
It is assumed that reactive astrogliosis occurs in response to
all forms of CNS injury or disease. However, gliotic changes
in the degenerating retina may have very different features,
depending upon the etiology, severity, and duration of the
disease (Ridet et al., 1997; Sofroniew, 2005). Degenerative retinal
diseases have been associated with both increases and decreases
in astrocyte density. Decreases in the number of astrocytes
have been observed in AMD (Ramírez et al., 2001) and during
streptozotocin (STZ)-induced diabetes (Ly et al., 2011). The
loss of astrocytes is also correlated with the development of
pathological retinal neovascularization (Dorrell et al., 2010). On
the contrary, no changes or increases in astrocyte density have
been described in glaucoma (Wang et al., 2002; Formichella et al.,
2014). Our results indicated an increase in astrocyte cell number
in P23H rat retinas, as compared to control SD rats at 4 and
12 months of age, when the retina is undergoing a dramatic
remodeling as a consequence of retinal degeneration. However,
no changes in the number of these cells were observed between
SD and P23H at 16 month of age, probably due to the slowdown
of the degenerative process in the P23H rat retina from 12 to
16 months. According to this idea, it has been described subtle
morphological changes in the P23H line 1 rat retina between 12
and 18 months of degeneration (Pinilla et al., 2015).
The function of astrogliosis is anything but clear, although
it has been linked to both protective and harmful effects (Ridet
et al., 1997; Sofroniew, 2005). In the acute stage, astrocyte
activation is believed to have a beneficial role, boosting the
cytoarchitectural remodeling needed to enable glial cells to
conserve tissue integrity by restricting the site of the lesion and
enhancing their essential neuroprotective function. It has been
demonstrated that, after an insult, reactive astrocytes demarcate
damaged tissue, restrict inflammation, stimulate the repair of
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FIGURE 9 | Müller and cone cell interactions in P23H rat retinas. Whole-mounted retinas from P360 P23H rats showing single (A,B) and double (C,D) staining
with γ-transducin (green) and GFAP (red) for labeling cone and reactive Müller cells, respectively. The retinas were flat-mounted with the photoreceptor layer facing up.
Note the presence of degenerating cones with short outer segments and axons (A,B, arrowheads). High magnification of a degenerated cone is shown in (B) (lower
left corner, inset a). (E,F) Magnification of (B,D) (inset b), respectively, showing cones with normal morphology [E, outer segment (empty arrow), inner segment (empty
arrowhead), axons (arrow), and pedicles (arrowhead)] and Müller cell apical processes (red) arranged in parallel to the cones (F). Scale bar: 100µm (A,C), 10µm (Inset
a), 40µm (B,D–F).
the blood-brain barrier, counteract edema, and protect neurons
and neural function (Sofroniew, 2005). Conversely, prolonged
activation can interfere with neuronal survival and regeneration.
Using antibodies against Cx43, we observed that Cx43-IR
puncta were closely associated with GFAP-IR astrocyte processes
at the GCL in both SD and P23H rats. These results are
in accordance with previous studies showing Cx43-IR puncta
following GFAP-IR astrocyte processes on the inner surface
of the rat retina (Kerr et al., 2010), and imply that the gap
junctions formed by retinal astrocytes contain Cx43. Cx43-IRwas
previously detected in the GCL of rat retinas (Janssen-Bienhold
et al., 1998). In humans, Cx43-IR has been found on GFAP-
positive astrocytes in the retinal GCL and on the optic nerve
head (Kerr et al., 2011). In P23H rat retinas, the density of Cx43-
IR puncta within the GCL and the GFAP protein expression
were greater than in SD rat retinas. Increased Cx43 expression
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has been previously described following acute injury to the CNS
(Lee et al., 2005; Nakase et al., 2006; Haupt et al., 2007) and in
neurodegenerative diseases (Rufer et al., 1996; Vis et al., 1998).
In glaucomatous eyes, increased Cx43-IR was observed in the
peripapillary and mid-peripheral retina, in association with glial
activation (Kerr et al., 2011). These observations may suggest
a role for Cx43 in the pathogenesis of neurodegeneration. The
higher expression of Cx43 and the increase in Cx43-IR puncta
observed in P23H rats were in correlation with the astrocyte
cell hypertrophy observed in these animals. The main features
of this hypertrophy are the elongation and proliferation of
astrocyte processes, as well as the swelling of both cell bodies and
processes, which is reflected in the complexity of the astrocytic
network. In this context, because the number of astrocytes
increased 20% and 23% in P120 and P360 P23H rat retinas,
respectively, as compared to control animals and the increase
in Cx43 expression levels detected by Western blot was much
higher (125 and 82% respectively), we suggest an increment of
Cx43 expression per astrocyte. The overall increase in Cx43 could
be the consequence of both the increased number of astrocytes
and of their complexity in order to maintain the communication
between adjacent cells throughout gap-junctions.
It is assumed that retinal diseases and injuries upregulate
the GFAP, as well as additional intermediate filament proteins;
this is thought to occur primarily in the Müller cells (Fisher
and Lewis, 2003; Bringmann et al., 2006; Bringmann and
Wiedemann, 2012). Thus, a common feature of all retinal
diseases, including RP, glaucoma, DR, and AMD in both
animal models and humans, is the presence of a high level
of GFAP in Müller cells (Madigan et al., 1994; Strettoi et al.,
2002; Wang et al., 2002; Gerhardinger et al., 2005; Inman
and Horner, 2007; Vogler et al., 2014; Hippert et al., 2015).
This effect has been related to modifications in a potassium
channel referred to as KCNQ5, suggesting a relationship between
cytoskeletal proteins such as GFAP, andmembrane proteins, such
as potassium channels (Caminos et al., 2015). In addition to
the increase in intermediate filament proteins, reactive Müller
cells may become hypertrophied, resulting in a proliferation of
fibrous processes on the outer edge of the retina (Fisher and
Lewis, 2003; Marc and Jones, 2003; Gargini et al., 2007; Ray
et al., 2010; Cuenca et al., 2014). The expanded Müller cell
processes occupy the space left by the dying photoreceptors.
We observed that GFAP immunoreactivity within Müller cells
was markedly greater in P23H rats than that observed in age-
matched control rats. In normal retinas, GFAP immunoreactivity
was not detected, while diseased retinas showed intense GFAP
immunoreactivity within the entire cell, from their end-feet to
the outer limiting membrane. Moreover, hypertrophied branches
of Müller cells were observed into the ONL of diseased
retinas.
In parallel with the immunohistochemistry data, Western
blotting results showed a large increase in GFAP protein
expression in the retina of P23H rats, as compared to the control
animals. This increment reflects GFAP expression in the activated
Müller cells. However, it is important to note that the astrocytic
hyperplasia and hypertrophy observed in the degenerative retina
of P23H rats also contribute to the upregulation of GFAP
expression. Additionally, in P23H rat retinas, GFAP expression
also increases with the age of the animal, indicating enhanced
activation of glial cells in the advanced stages of retinal
degeneration. The function of increased GFAP expression in
Müller cells is unknown, although is thought to help stabilize
the newly formed terminal processes of Müller cells and provide
resistance to mechanical stress (Lundkvist et al., 2004; Verardo
et al., 2008). Furthermore, increased levels of GFAP would seem
to be essential for a multitude of responses during Müller cell
gliosis, such as the formation of glial scars, neurite growth,
infiltration of monocytes, neovascularization, and the integration
of cells in retinal transplants, as all these characteristics were
found to be attenuated in GFAP- and vimentin-deficient mice,
which are an experimental animal model of retinal detachment
(Lewis and Fisher, 2003; Nakazawa et al., 2007; Bringmann et al.,
2009).
The cytoarchitecture of the outer nuclear layer is, at least
in part, maintained by a network of heterotypic adherens
junction complexes that form the outer limiting membrane
(OLM) (Williams et al., 1990). These junctions connect the inner
segments of photoreceptors to the apical processes ofMüller cells,
and thus photoreceptor death is likely to disrupt the OLM, and
compromise the orientation and polarity of the photoreceptors
(Hippert et al., 2015). In this study, the regular distribution
and orientation of cone cells was disrupted by the appearance
of ring-shaped areas of cone degeneration, with Müller cell
apical processes forming clusters that resembled fireworks. This
peculiar disposition of cones and apical Müller cell processes has
been previously described in the S334ter-line-3 rat (Lee et al.,
2011; Ji et al., 2015) and the P23H line 1 rat (García-Ayuso et al.,
2013) models of RP. In agreement with previous studies (Cuenca
et al., 2004, 2014; Lu et al., 2013), as photoreceptor degeneration
progressed, cone morphology underwent progressive changes,
including the shortening of both outer segments and axons.
However, our results show for the first time that Müller cell
apical processes are arranged parallel to some cones, which retain
normal morphology in advanced stages of retinal degeneration.
We also show that the spatial correlation between ring-like
shaped areas of cone cells and firework-like structures of Müller
cell apical processes are transient structures that disappear in late
stages of retinal degeneration.
One can hypothesize that the loss of photoreceptors in this
RP model, the P23H rat, induces changes in retinal vasculature
(Villegas-Pérez et al., 1998; Pennesi et al., 2008), which, in
turn, may induce the activation of astrocytes and Müller
cells. However, given that retinal macroglia is essential for the
maintenance of retinal homeostasis, morphological changes, and
activation of astrocytes and Müller cells can induce inner retinal
remodeling (Marc et al., 2003; Cuenca et al., 2004, 2014; Jones
and Marc, 2005; Puthussery and Taylor, 2010; Jones et al., 2012),
including ganglion cell degeneration (Jones et al., 2003; García-
Ayuso et al., 2010; Kolomiets et al., 2010). The disruption of
blood vessels can affect the normal oxygen and nutrient supply
to retinal cells, and thereby accelerate the progress of retinal
degeneration. Most likely, inner retinal remodeling is mediated
by changes in both retinal vasculature and macroglial cells after
photoreceptor death in retinitis pigmentosa.
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Supplementary Figure 1 | Cone cells in SD and P23H rat retinas. Vertical
retinal sections from a SD rat (A) and a P23H rat at P120 stained with
γ-transducin, showing the morphology of normal cones in SD rats and
degenerating cones in P23H rats. Note the typical cone shape in SD rats, where
outer (empty arrows) and inner segments (empty arrowheads), axons (arrows) and
pedicles (arrowheads) are clearly recognizable. By contrast, in P23H rat retinas the
cone outer segments are both short and swollen and very small in size, the axons
are nor identifiable and pedicles seem to emerge directly from the cone cell
bodies. Both images were collected from the central area of the retina, close to
the optic nerve. Scale bar: 20µm.
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